TFToshio Fujioka

Toshio Fujioka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toshio Fujioka has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Complete pancreas divisum with patulous minor papilla complicated by multifocal branch-duct intraductal papillary mucinous neoplasms

    by Y. Nakagawa, M. Yamauchi, R. Ogawa, M. Watada, K. Mizukami, T. Okimoto, M. Kodama, K. Murakami, T. Fujioka

    A 70-year-old Japanese woman who did not drink alcohol was admitted for investigation into the cause of her recurrent acute pancreatitis. On admission, an abdominal computed tomography (CT) scan revealed dilatation of the dorsal pancreatic duct and multifocal branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) that had enlarged relative to images that had been taken 3 years previously ([Fig. 1]). Magnetic resonance cholangiopancreatography (MRCP) also showed multifocal BD-IPMNs ([Fig. 2 a]) but could not detect the duct of Wirsung ([Fig. 2 b]). The largest cyst of the BD-IPMNs was < 3 cm and without mural nodules. Endoscopic retrograde pancreatography was unsuccessful via the major papilla, but successful via the minor papilla. The minor papilla was patulous, with a large amount of mucin being secreted from the orifice ([Fig. 3]). From these findings, a diagnosis of complete pancreas divisum complicated by multifocal BD-IPMNs was made. A dorsal duct stent was placed via the minor papilla, but was displaced 2 days later, so surgical intervention was required. Pancreas divisum is the most common congenital variation of pancreatic duct anatomy, arising when the embryological ventral and dorsal endodermal buds fail to fuse. Whether pancreas divisum causes acute or chronic pancreatitis remains controversial [1] [2], but despite this some authors consider dorsal duct obstruction caused by the relative stenosis of the minor papilla to be a factor in the development of pancreatitis [3] [4]. In addition, 25 % – 41 % of all BD-IPMNs are multifocal, although their treatment should mirror that of unifocal BD-IPMNs [5]. In this case, it was likely that the recurrent acute pancreatitis was due to the complete pancreas divisum and to the large amount of pancreatic juice being secreted by the enlarging multifocal BD-IPMNs. To the best of our knowledge, this is the first case to be reported in the English literature of complete pancreas divisum complicated by multifocal BD-IPMNs. In addition, we have provided a vivid endoscopic image of the patulous minor papilla secreting a large amount of mucin. Endoscopy_UCTN_Code_CCL_1AZ_2AB


  • Hemorrhagic pseudoaneurysm in a pancreatic pseudocyst after extracorporeal shock wave lithotripsy for pancreatolithiasis

    by Y. Nakagawa, T. Abe, M. Uchida, K. Inoue, R. Ogawa, K. Mizukami, T. Okimoto, M. Kodama, K. Murakami, T. Fujioka

    A 49-year-old man with a history of alcohol abuse and chronic pancreatitis was referred to our hospital for extracorporeal shock wave lithotripsy (ESWL) for pancreatolithiasis. Computed tomography (CT) revealed chronic pancreatitis with a pseudocyst (diameter, 30 mm) in the pancreatic tail and multiple pancreatic calculi ([ Fig. 1 a, b ]). Fig. 1 Abdominal computed tomography (CT) scan showing: a a pseudocyst (30 mm in diameter) in the pancreatic tail, without a pseudoaneurysm, in a contrast-enhanced scan prior to extracorporeal shock wave lithotripsy (ESWL); b chronic pancreatitis with multiple calculi in an unenhanced scan prior to ESWL; c enlargement of the pseudocyst (50 mm in diameter) in a contrast-enhanced scan after ESWL; d a hemorrhagic pseudoaneurysm in the enlarged pseudocyst. We initially performed an endoscopic pancreatic sphincterotomy then administered four courses of ESWL without noting any remarkable improvement in the pancreatolithiasis. The patient experienced sudden, severe upper abdominal pain 6 days after the fourth course of ESWL. A contrast-enhanced CT scan showed enlargement of the pseudocyst (diameter, 50 mm) and a hemorrhagic pseudoaneurysm in the cyst ([ Fig. 1 c, d ]). Selective celiac angiography revealed a pseudoaneurysm in the pancreatic branch of the splenic artery ([ Fig. 2 ]). Fig. 2 Selective celiac angiography showing a pseudoaneurysm in the pancreatic branch of the splenic artery. Transcatheter arterial embolization with a mixture of n-butyl-2-cyanoacrylate and iodized oil resulted in hemostasis of the pseudoaneurysm. During a 3-year follow-up, he experienced no further bleeding. Hemorrhagic pseudoaneurysm in a pancreatic pseudocyst is a serious complication of pancreatitis, with a reported mortality rate of 18 % – 29 % in treated patients and > 90 % in untreated patients [ 1 ]. Pseudoaneurysms are formed by the enzyme-rich peripancreatic fluid of the pseudocyst, which causes autodigestion and weakening of the walls of the adjacent arteries [ 2 ]. Although ESWL is a highly effective and safe treatment for calculi of the main pancreatic duct [ 3 ] and other organs, renal hematoma is one of the most significant adverse effects of ESWL [ 4 ]. This renal hemorrhage suggests that ESWL causes renal cellular injury and ultrastructural damage in kidney tissues [ 4 ]. In our case, the appearance of the pseudoaneurysm may have been triggered by ESWL. To the best of our knowledge, this is the first case report in English of hemorrhagic pseudoaneurysm in a pancreatic pseudocyst after ESWL. We conclude that the risk of hemorrhagic pseudoaneurysm in a pancreatic pseudocyst must be considered during ESWL for pancreatolithiasis. Endoscopy_UCTN_Code_CCL_1AZ_2AH


  • Acute hemorrhagic colitis induced by the oral administration of oseltamivir used for influenza A treatment

    by Y. Nakagawa, T. Nagai, H. Okawara, H. Nakashima, A. Hisamatsu, M. Shuto, M. Yamauchi, S. Kai, S. Yokoyama, K. Murakami, et al.

    A 40-year-old woman with a history of bronchial asthma was diagnosed with influenza A using a rapid diagnosis kit. She began to experience abdominal pain, diarrhea, and hematochezia approximately 4 hours after a single capsule of oseltamivir had been administered. Colonoscopic findings indicated circumferential hemorrhagic colitis with longitudinal erosions in the descending colon, findings which mimicked those of ischemic colitis ([ Fig. 1 ]). Histopathological analysis of the lesion showed the presence of mucosal hemorrhage and submucosal edema ([ Fig. 2 ]). Stool culture showed normal flora. Discontinuation of the oseltamivir therapy was followed by an immediate improvement in the hemorrhagic colitis. The lymphocyte transformation test (LTT) yielded positive results for oseltamivir only, with negative results for the other drugs administered, which included clarithromycin and acetaminophen. Fig. 1 Colonoscopic findings in the descending colon showing acute circumferential hemorrhagic colitis, with hemorrhage, edema, segmental erythema, and longitudinal erosion. Fig. 2 Photomicrographs of the hematoxylin and eosin (H&E)-stained biopsy specimens from the descending colon showing: a mucosal hemorrhage and submucosal edema, magnification × 40; b mucosal hemorrhage, magnification × 400. Oseltamivir, a neuraminidase inhibitor, plays a key role in the management of influenza. The most commonly reported adverse effect of oseltamivir is gastrointestinal discomfort [ 1 ] [ 2 ]. Oseltamivir-induced acute hemorrhagic colitis (OAHC) is very rare, and to the best of our knowledge, there has been only one case of OAHC reported in the literature in English [ 3 ]. However, the Japanese Ministry of Health, Labor and Welfare provided data on oseltamivir-linked gastrointestinal bleeding, and consequently, the summary of product characteristics for oseltamivir was modified in 2005 to include hemorrhagic colitis. Matsushita et al. reported that ischemia might be involved in the pathogenesis of OAHC [ 3 ]. The colonoscopic findings in our patient, who had no other risk factors for ischemia, mimicked those of ischemic colitis. Toffler et al., in their report, attributed ischemia to allergic vasculitis [ 4 ]. The positive LTT results for our patient suggest that the OAHC was induced by drug allergy; however, the detailed mechanism that underlies OAHC has not been clarified. To the best of our knowledge, this is the first report in English that details a case of OAHC with positive LTT results for oseltamivir. In conclusion, the risk of OAHC must be considered before prescribing the drug. Endoscopy_UCTN_Code_CCL_1AD_2AJ


  • Minute primary extramedullary plasmacytomas of the large intestine

    by Y. Nakagawa, T. Nagai, H. Okawara, H. Nakashima, A. Hisamatsu, M. Syutou, M. Yamauchi, S. Kai, T. Nakayama, S. Yokoyama, et al.

    An 84-year-old woman underwent a follow-up colonoscopy 4 years after undergoing endoscopic mucosal resection (EMR) for colonic adenoma. Two small polyps were found in the cecum and the rectum ([ Fig. 1 a, b ]) and EMR was performed. Fig. 1 Endoscopic appearance of primary extramedullary plasmacytomas. a In the cecum, the slightly reddish sessile polyp with a normal surface was suggestive of a submucosal tumor. b In the rectum, the mucosal surface of the tumor was different from the surrounding normal mucosa, suggesting an epithelial tumor. Histologically, both resected specimens showed a dense infiltration of plasma cells ([ Fig. 2 a, b ]). Fig. 2 Low-power view of primary extramedullary plasmacytomas: a cecal; b rectal. They were considered to be monoclonal neoplastic cells because they were immunohistochemically positive for kappa light chains but negative for lambda light chains ([ Fig. 3 a, b ]). Fig. 3 Immunohistochemical staining for primary extramedullary plasmacytomas: a kappa light chains; b lambda light chains. A subsequent skeletal survey and bone marrow aspirate biopsy were normal. No monoclonal paraprotein was identified in the serum or urine, and there was no hypercalcemia or renal failure. Upper gastrointestinal endoscopy showed atrophic gastritis only. Dynamic computed tomography showed no lesion associated with the plasmacytoma. On the basis of these results, a diagnosis of primary extramedullary plasmacytomas (PEMPs) of the cecum and rectum was made. The diagnosis of PEMP requires demonstration of a monoclonal plasma cell infiltration without evidence of multiple myeloma [ 1 ] [ 2 ]. Approximately 10 % of PEMPs are found in the gastrointestinal tract [ 3 ] [ 4 ]. PEMP of the large intestine is extremely rare, and to the best of our knowledge, only 13 previous cases of PEMP of the large intestine have been reported in the English literature. All of these previous cases were symptomatic, advanced, single tumors, which underwent surgical treatment, except for one case which was resected using EMR [ 5 ]. Tumors in these cases have no special endoscopic appearance, and only one endoscopic image has been published [ 5 ]. In our case, we described two minute PEMPs (cecum = 4 mm in diameter; rectum = 2 mm in diameter) without symptoms in the large intestine with clear endoscopic images. To our knowledge, there are no similar previous reports. In conclusion, our case is very important for the understanding of the early morphology of PEMP in the large intestine. Endoscopy_UCTN_Code_CCL_1AD_2AC


  • Saline-Assisted Endoscopic Resection of Rectal Carcinoids: Cap Aspiration Method Versus Simple Snare Resection

    by T. Nagai, R. Torishima, H. Nakashima, H. Ookawara, A. Uchida, S. Kai, R. Sato, K. Murakami, T. Fujioka

    Background and Study Aims: Complete resection of small carcinoid tumors of the rectum is difficult during endoscopic polypectomy, because these tumors are often located in the submucosal layer of the rectal wall. To completely remove these tumors, we have used aspiration lumpectomy. In this study, we evaluated its clinical usefulness in comparison with strip biopsy. Patients and Methods: We performed strip biopsy (December 1996 through March 2000) or aspiration lumpectomy (April 2000 through February 2003) in a consecutive series of patients with rectal carcinoid tumor. Eight carcinoid tumors in eight patients were resected by strip biopsy, and eight tumors in eight patients were resected by aspiration lumpectomy. Results: The rate of complete removal of carcinoid tumors with aspiration lumpectomy (100 %) was significantly higher (P < 0.05) than that with strip biopsy (37.5 %). Conclusions: Endoscopic resection with aspiration lumpectomy is a useful and safe method for resection of small carcinoid tumors of the rectum.


  • Open Access

    Effects of rebamipide, a gastro‐protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double‐blind placebo‐controlled multicentre trial

    by T. Fujioka, T. Arakawa, T. Shimoyama, T. Yoshikawa, M. Itoh, M. Asaka, H. Ishii, H. Kuwayama, R. Sato, S. Kawai, et al.

    Aims : To investigate the effects of rebamipide on the Helicobacter pylori eradication rate with amoxicillin and omeprazole. The trial also examined its histological effects on gastro‐mucosal inflamm...


  • Open Access

    Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment

    by T. Sugiyama, N. Sakaki, H. Kozawa, R. Sato, T. Fujioka, K. Satoh, K. Sugano, H. Sekine, A. Takagi, Y. Ajioka, et al.

    Background: Helicobacter pylori infection is a major cause of the progress of gastric glandular atrophy, a high‐risk background factor in the development of gastric cancer. Regression of gastric atrophy is critical to prevention of cancer by H. pylori eradication treatment. However, it is controversial whether gastric atrophy regresses after H. pylori eradication. Aim: To determine the most sensitive and appropriate biopsy site for evaluation of regression of atrophy after treatment. Subjects and methods: Thirty‐eight patients who showed regression of gastric atrophy in histology after treatment were investigated. Four biopsy specimens from the lesser and greater curvatures in the antrum and corpus were evaluated before and after treatment according to the Updated Sydney System. Results: Regression of atrophy after treatment was seen in 30 of 38 biopsy specimens from the lesser curvature of the corpus (79%), and this site was most sensitive. Odds ratio of this site to the others was 8.28. Regression of atrophy in this site was observed at 12.2 months in the younger patients and 15.9 months in the elder patients. Conclusion: Biopsy sampling from the lesser curvature of the corpus is the most sensitive and appropriate for evaluation of regression of gastric atrophy after H. pylori eradication treatment.


  • Helicobacter pylori and gastric carcinoma -from the view point of animal model

    by Toshio Fujioka, Kazunari Murakami, Masaaki Kodama, Jiro Kagawa, Tadayoshi Okimoto, Ryugo Sato

    Many epidemiological studies have shown a strong association between chronic Helicobacter pylori infection and subsequent development of gastric carcinoma in humans. To confirm this link more clearly, it is necessary to use this bacterium in experimental studies to develop gastric carcinoma in suitable experimental animals. Persistent H. pylori infection has recently been achieved in the Japanese Monkeys and Mongolian gerbil models, with results demonstrating that the sequential histopathological changes in the gastric mucosa are closely mimic the gastric mucosal changes caused by H. pylori infection in humans. Gastric mucosa infected with H. pylori exhibited significantly higher gastritis score, reduction in glandular height, increase in the number of Ki-67 positive cells and over expression of p53 protein and p53 gene mutation in the Japanese Monkey Model. In the Mongolian gerbil model, H. pylori infection enhances gastric carcinogenesis in combination with known carcinogens such as MNU and MNNG, and also demonstrated that H. pylori infection alone can result in the development of gastric carcinoma. However, diagnostic criteria of gastric carcinoma in animal models remain in the great discussion. These important results provide a starting point for further studies to clarify the mechanism of gastric carcinogenesis as a result of H. pylori infection and assist the planning of eradication therapy to prevent gastric carcinoma.


    • 1 February 2001
      • Vol. 59  (2) , 308-13

    [Selection of antibiotics and planning of eradication for H. pylori infection].

    by K Murakami, R Satoh, T Okimoto, J Kagawa, T Fujioka, M Kodama

    There is general agreement that H. pylori should be eradicated in patients with peptic ulcers. But the optimal therapeutical regimen to be used still remains a matter for many investigations. An increase in the prevalence of antibiotic-resistant H. pylori strains has been reported recently. The recommended drugs for the eradication in Japan are clarithromycin (CAM) and amoxicillin (AMPC) because metronidazole (MNZ) is anti-parasites drug in Japan. A total of 392 H. pylori strains in the last twelve years were tested for sensitivity to CAM, MNZ, and AMPC. The Primary resistance of H. pylori to CAM, MNZ, and AMPC were found in 10.2%, 26.5%, and 0.3% strains, respectively. The resistant strains to CAM were gradually increasing in the last few years. The eradication therapies which do not increase antibiotics resistant strains after eradication failure were reported. The recommendation for eradication in patients with peptic ulcer disease includes those with bleeding ulcers. The pretreatment with proton pump inhibitors (PPI) does not influence the success of PPI-based triple therapy in eradicating H. pylori.

    • 1 February 2001
      • Vol. 49  (2) , 130-4

    [Eradication therapy of Helicobacter pylori infection].

    by M Kodama, T Fujioka

    Helicobacter pylori(H. pylori) infection is recognized to be a pathogen of various gastro-duodenal diseases. Eradication therapy of H. pylori reduces the recurrence of gastro-duodenal ulcer, and improves gastritis histologically. Recently, proton pump inhibitor(PPI) based triple therapy, that combining PPI, clarithromycin, amoxicillin is widely accepted throughout the world, and shows high eradication rate which ranged about 80-90%. In Japan, one week triple therapy is recommended for the treatment of gastro-duodenal ulcer, though it is expected the improvement of recurrent peptic ulcer. In the present studies, the rate of clarithromycin resistant strains has been increased gradually, and this fact may lead to the development of failure of PPI based triple therapy. Another problem is suggested by several studies that gastro-esophageal reflux disease(GERD) may increase after successful eradication of H. pylori. Reflux esophagitis and Barrett's esophagus are recognized as precancerous lesion of esophageal adenocarcinoma, but the association of newly occurrence of GERD after H. pylori eradication and increase of esophageal adenocarcinoma is not clear. Merits and demerits of H. pylori eradication need to be observed carefully over a long term.